Terms: = Thyroid cancer AND EP300, ENSG00000100393, 2033, RP1-85F18_1, p300
57 results:
1. Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer.
Jiang C; Zhu Y; Chen H; Lin J; Xie R; Li W; Xue J; Chen L; Chen X; Xu S
Cell Death Dis; 2023 Oct; 14(10):653. PubMed ID: 37803002
[TBL] [Abstract] [Full Text] [Related]
2. Hypoxia switches TET1 from being tumor-suppressive to oncogenic.
Yang Q; Dang H; Liu J; Wang X; Wang J; Lan X; Ji M; Xing M; Hou P
Oncogene; 2023 May; 42(20):1634-1648. PubMed ID: 37020036
[TBL] [Abstract] [Full Text] [Related]
3. The expression of HDAC9 and p300 in papillary thyroid carcinoma cell line.
Ozisik H; Ozdil B; Suner A; Sipahi M; Erdogan M; Cetinkalp S; Ozgen G; Saygili F; Oktay G; Aktug H
Pathol Res Pract; 2023 Mar; 243():154385. PubMed ID: 36857949
[TBL] [Abstract] [Full Text] [Related]
4. thyroid Hormone Induces Oral cancer Growth via the PD-L1-Dependent Signaling Pathway.
Su KW; Lin HY; Chiu HC; Shen SY; ChangOu CA; Crawford DR; Yang YSH; Shih YJ; Li ZL; Huang HM; Whang-Peng J; Ho Y; Wang K
Cells; 2022 Sep; 11(19):. PubMed ID: 36231010
[TBL] [Abstract] [Full Text] [Related]
5. Somatic Mutation Profiling of Papillary thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.
Qi T; Rong X; Feng Q; Sun H; Cao H; Yang Y; Feng H; Zhu L; Wang L; Du Q
Int J Med Sci; 2021; 18(12):2532-2544. PubMed ID: 34104084
[TBL] [Abstract] [Full Text] [Related]
6. Bcl-2-negative IGH-BCL2 translocation-negative follicular lymphoma of the thyroid differs genetically and epigenetically from Bcl-2-positive IGH-BCL2 translocation-positive follicular lymphoma.
Hamamoto Y; Kukita Y; Kitamura M; Kurashige M; Masaie H; Fuji S; Ishikawa J; Honma K; Wakasa T; Hanamoto H; Hirokawa M; Suzuki A; Morii E; Nakatsuka SI
Histopathology; 2021 Oct; 79(4):521-532. PubMed ID: 33829512
[TBL] [Abstract] [Full Text] [Related]
7. The role of PKM2 nuclear translocation in the constant activation of the NF-κB signaling pathway in cancer-associated fibroblasts.
Gu J; Li X; Zhao L; Yang Y; Xue C; Gao Y; Li J; Han Q; Sun Z; Bai C; Zhao RC
Cell Death Dis; 2021 Mar; 12(4):291. PubMed ID: 33731686
[TBL] [Abstract] [Full Text] [Related]
8. Comparison of Survival Outcomes Among Patients With Breast cancer With Distant vs Ipsilateral Supraclavicular Lymph Node Metastases.
Pan H; Wang H; Qian M; Mao X; Shi G; Ma G; Yu M; Xie H; Ling L; Ding Q; Zhang K; Wang S; Zhou W
JAMA Netw Open; 2021 Mar; 4(3):e211809. PubMed ID: 33724394
[TBL] [Abstract] [Full Text] [Related]
9. CT imaging findings of lenvatinib-induced enteritis.
Kurokawa R; Hagiwara A; Tanishima T; Inui S; Kurokawa M; Nakaya M; Gonoi W; Amemiya S; Nakai Y; Fujita N; Ota Y; Baba A; Abe O
Abdom Radiol (NY); 2021 Jul; 46(7):3066-3074. PubMed ID: 33674959
[TBL] [Abstract] [Full Text] [Related]
10. Targeted next-generation sequencing assays using triplet samples of normal breast tissue, primary breast cancer, and recurrent/metastatic lesions.
Akahane T; Kanomata N; Harada O; Yamashita T; Kurebayashi J; Tanimoto A; Moriya T
BMC Cancer; 2020 Oct; 20(1):944. PubMed ID: 33004031
[TBL] [Abstract] [Full Text] [Related]
11. Second primary cancers in people who had cancer as children: an Australian Childhood cancer Registry population-based study.
Youlden DR; Baade PD; Green AC; Valery PC; Moore AS; Aitken JF
Med J Aust; 2020 Feb; 212(3):121-125. PubMed ID: 31743457
[TBL] [Abstract] [Full Text] [Related]
12. Long noncoding RNA SAMMSON promotes papillary thyroid carcinoma progression through p300/Sp1 axis and serves as a novel diagnostic and prognostic biomarker.
Shao L; Sun W; Wang Z; Dong W; Qin Y
IUBMB Life; 2020 Feb; 72(2):237-246. PubMed ID: 31478331
[TBL] [Abstract] [Full Text] [Related]
13. Risk of malignancy and neoplasia predicted by three molecular testing platforms in indeterminate thyroid nodules on fine-needle aspiration.
Partyka KL; Trevino K; Randolph ML; Cramer H; Wu HH
Diagn Cytopathol; 2019 Sep; 47(9):853-862. PubMed ID: 31245935
[TBL] [Abstract] [Full Text] [Related]
14. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA 675 cooperates PKM2 to aggravate progression of human liver cancer stem cells induced from embryonic stem cells.
Yang Y; Meng Q; Wang C; Li X; Lu Y; Xin X; Zheng Q; Lu D
J Mol Med (Berl); 2018 Oct; 96(10):1119-1130. PubMed ID: 30140938
[TBL] [Abstract] [Full Text] [Related]
16. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
[TBL] [Abstract] [Full Text] [Related]
17. NOX4 functions as a mitochondrial energetic sensor coupling cancer metabolic reprogramming to drug resistance.
Shanmugasundaram K; Nayak BK; Friedrichs WE; Kaushik D; Rodriguez R; Block K
Nat Commun; 2017 Oct; 8(1):997. PubMed ID: 29051480
[TBL] [Abstract] [Full Text] [Related]
18. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
19. Identification of Novel Oncogenic Mutations in thyroid cancer.
Pitt SC; Hernandez RA; Nehs MA; Gawande AA; Moore FD; Ruan DT; Cho NL
J Am Coll Surg; 2016 Jun; 222(6):1036-1043.e2. PubMed ID: 27010584
[TBL] [Abstract] [Full Text] [Related]
20. MED27 promotes melanoma growth by targeting AKT/MAPK and NF-κB/iNOS signaling pathways.
Tang R; Xu X; Yang W; Yu W; Hou S; Xuan Y; Tang Z; Zhao S; Chen Y; Xiao X; Huang W; Guo W; Li M; Deng W
Cancer Lett; 2016 Apr; 373(1):77-87. PubMed ID: 26797421
[TBL] [Abstract] [Full Text] [Related]
[Next]
